Izindaba zenkampani
-
Izindaba Ezijabulisayo | I-JYMed's Liraglutide API Ithola Isitifiketi Se-WC
Ngomhla ziyi-12 kuMfumfu, 2024, i-JYMed's Liraglutide API yathola isitifiketi Sokuqinisekisa Okubhaliwe (WC), okumaka isinyathelo esibalulekile sokuthunyelwa ngempumelelo kwe-API emakethe ye-EU. I-WC (Isiqiniseko Esibhaliwe)...Funda kabanzi -
Sihalalisela I-Tirzepatide ye-JYMed Iqeda Ukugcwalisa kwe-US-DMF
I-JYMed Technology Co., Ltd. iyajabula ukumemezela ukuthi umkhiqizo wayo, i-Tirzepatide, iqede ngempumelelo ukubhaliswa kwe-Drug Master File (DMF) ne-US FDA (Inombolo ye-DMF: 040115) futhi yathola I-Acknowl ye-FDA...Funda kabanzi -
I-JYMed Peptide ikumema ukuthi uhambele uMbukiso Wezithako Zezimonyo wase-Korea wango-2024
Indawo: Isikhungo Sombukiso Samazwe Ngamazwe sase-Korea Usuku: Julayi 24-26, 2024 Isikhathi: 10:00 AM - 5:00 PM Ikheli: I-COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 I-In-cosmetics iyiqembu elihamba phambili lemibukiso yomuntu siqu embukisweni wamazwe ngamazwe...Funda kabanzi
